The medical sector is witnessing a major shift in glucose care with the arrival of GLP-1 transdermal devices. These innovative vehicles offer a likely convenient choice to needle injections for individuals living with type 2 diabetes. By bypassing the need for frequent injections, GLP-1 patches p